Teva soars on ‘positive’ trial results for inflammatory bowel disease treatment

Trial results showed that patients treated with antibody ‘duvakitug,’ jointly developed with French drug-maker Sanofi, achieved a higher rate of clinical remission

The post Teva soars on ‘positive’ trial results for inflammatory bowel disease treatment appeared first on The Times of Israel.